FPHAX vs. FSPTX
Compare and contrast key facts about Fidelity Select Pharmaceuticals Portfolio (FPHAX) and Fidelity Select Technology Portfolio (FSPTX).
FPHAX is managed by Fidelity. It was launched on Jun 17, 2001. FSPTX is managed by Fidelity. It was launched on Jul 13, 1981.
Performance
FPHAX vs. FSPTX - Performance Comparison
Loading graphics...
FPHAX vs. FSPTX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FPHAX Fidelity Select Pharmaceuticals Portfolio | -2.56% | 30.41% | 9.39% | 12.54% | 0.94% | 11.79% | 11.16% | 31.73% | 5.41% | 10.70% |
FSPTX Fidelity Select Technology Portfolio | -8.57% | 23.37% | 41.76% | 59.83% | -36.91% | 21.99% | 63.95% | 51.08% | -9.03% | 49.75% |
Returns By Period
In the year-to-date period, FPHAX achieves a -2.56% return, which is significantly higher than FSPTX's -8.57% return. Over the past 10 years, FPHAX has underperformed FSPTX with an annualized return of 10.94%, while FSPTX has yielded a comparatively higher 22.24% annualized return.
FPHAX
- 1D
- 0.57%
- 1M
- -9.52%
- YTD
- -2.56%
- 6M
- 15.21%
- 1Y
- 27.23%
- 3Y*
- 16.20%
- 5Y*
- 11.88%
- 10Y*
- 10.94%
FSPTX
- 1D
- -2.07%
- 1M
- -7.34%
- YTD
- -8.57%
- 6M
- -7.04%
- 1Y
- 31.57%
- 3Y*
- 26.70%
- 5Y*
- 13.98%
- 10Y*
- 22.24%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FPHAX vs. FSPTX - Expense Ratio Comparison
FPHAX has a 0.75% expense ratio, which is higher than FSPTX's 0.67% expense ratio.
Return for Risk
FPHAX vs. FSPTX — Risk / Return Rank
FPHAX
FSPTX
FPHAX vs. FSPTX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity Select Pharmaceuticals Portfolio (FPHAX) and Fidelity Select Technology Portfolio (FSPTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FPHAX | FSPTX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.14 | 1.08 | +0.06 |
Sortino ratioReturn per unit of downside risk | 1.61 | 1.65 | -0.04 |
Omega ratioGain probability vs. loss probability | 1.21 | 1.23 | -0.02 |
Calmar ratioReturn relative to maximum drawdown | 2.05 | 1.78 | +0.27 |
Martin ratioReturn relative to average drawdown | 5.99 | 6.19 | -0.20 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| FPHAX | FSPTX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.14 | 1.08 | +0.06 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.67 | 0.52 | +0.16 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.62 | 0.86 | -0.25 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.52 | 0.52 | 0.00 |
Correlation
The correlation between FPHAX and FSPTX is 0.57, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
FPHAX vs. FSPTX - Dividend Comparison
FPHAX's dividend yield for the trailing twelve months is around 5.83%, less than FSPTX's 9.91% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FPHAX Fidelity Select Pharmaceuticals Portfolio | 5.83% | 5.68% | 1.90% | 8.08% | 5.18% | 11.09% | 8.85% | 8.33% | 1.65% | 1.62% | 1.07% | 12.63% |
FSPTX Fidelity Select Technology Portfolio | 9.91% | 9.06% | 9.42% | 0.01% | 3.95% | 11.62% | 18.86% | 1.86% | 23.77% | 8.32% | 1.54% | 4.19% |
Drawdowns
FPHAX vs. FSPTX - Drawdown Comparison
The maximum FPHAX drawdown since its inception was -38.26%, smaller than the maximum FSPTX drawdown of -84.37%. Use the drawdown chart below to compare losses from any high point for FPHAX and FSPTX.
Loading graphics...
Drawdown Indicators
| FPHAX | FSPTX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -38.26% | -84.37% | +46.11% |
Max Drawdown (1Y)Largest decline over 1 year | -11.00% | -15.49% | +4.49% |
Max Drawdown (5Y)Largest decline over 5 years | -28.82% | -42.16% | +13.34% |
Max Drawdown (10Y)Largest decline over 10 years | -28.82% | -42.16% | +13.34% |
Current DrawdownCurrent decline from peak | -9.82% | -13.71% | +3.89% |
Average DrawdownAverage peak-to-trough decline | -9.21% | -27.13% | +17.92% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.35% | 4.47% | -0.12% |
Volatility
FPHAX vs. FSPTX - Volatility Comparison
The current volatility for Fidelity Select Pharmaceuticals Portfolio (FPHAX) is 6.10%, while Fidelity Select Technology Portfolio (FSPTX) has a volatility of 6.73%. This indicates that FPHAX experiences smaller price fluctuations and is considered to be less risky than FSPTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| FPHAX | FSPTX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.10% | 6.73% | -0.63% |
Volatility (6M)Calculated over the trailing 6-month period | 14.17% | 16.55% | -2.38% |
Volatility (1Y)Calculated over the trailing 1-year period | 23.39% | 29.04% | -5.65% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 17.69% | 27.19% | -9.50% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.78% | 25.81% | -8.03% |